Qube Research & Technologies (QRT)
CNMD icon

Qube Research & Technologies (QRT)’s CONMED CNMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3M Sell
84,971
-138,383
-62% -$5.63M ﹤0.01% 1931
2025
Q4 		$9.07M Buy
223,354
+118,516
+113% +$5.16M 0.01% 1413
2025
Q3 		$4.93M Buy
104,838
+76,386
+268% +$3.96M 0.01% 1757
2025
Q2 		$1.48M Buy
28,452
+10,233
+56% +$562K ﹤0.01% 2315
2025
Q1 		$1.1M Sell
18,219
-4,977
-21% -$321K ﹤0.01% 2214
2024
Q4 		$1.59M Sell
23,196
-95,378
-80% -$6.65M ﹤0.01% 1974
2024
Q3 		$8.53M Sell
118,574
-7,208
-6% -$509K 0.01% 1131
2024
Q2 		$8.72M Sell
125,782
-1
-0% -$73 0.01% 977
2024
Q1 		$10.1M Buy
125,783
+99,300
+375% +$8.85M 0.02% 841
2023
Q4 		$2.9M Sell
26,483
-39,916
-60% -$4.13M 0.01% 1342
2023
Q3 		$6.7M Buy
+66,399
New +$7.63M 0.02% 807
2022
Q4 		– Sell
-15,470
Closed -$1.24M – 2535
2022
Q3 		$1.24M Buy
15,470
+10,830
+233% +$1.02M 0.01% 1119
2022
Q2 		$444K Buy
+4,640
New +$557K ﹤0.01% 1453
2020
Q1 		– Sell
-6,072
Closed -$679K – 1200
2019
Q4 		$679K Buy
+6,072
New +$647K 0.02% 798

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CNMD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its CONMED (CNMD) stake by 62% in Q1 2026, selling an estimated $5.63M and leaving 84,971 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Qube Research & Technologies (QRT) first reported a position in CNMD in Q4 2019 and has held it in 14 quarters since. The position peaked at $10.1M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 84,971 shares of CONMED worth $3M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 138,383 CONMED shares in Q1 2026, an estimated $5.63M.
  • CONMED made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1931 holding.
  • Qube Research & Technologies (QRT) first reported a position in CONMED in Q4 2019 and has held it in 14 quarters since.
  • Qube Research & Technologies (QRT)'s CONMED position peaked at $10.1M in Q1 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.